Skip to main content

Select Drug Profiles

Practice Management

Medical Care Costs and Hospitalization in Patients with Bipolar Disorder Treated with Atypical Antipsychotics

Joette Gdovin Bergeson, PhD, MPA, Iftekhar Kalsekar, PhD, Yonghua Jing, PhD, Min You, MS, Robert A. Forbes, PhD, Tony Hebden, PhD

Stakeholder Perspective

The Potential Value of Benefit Design and Medication Selection for a Total-Cost-of-Care Strategy in Bipolar Disease

by Jeff Januska, PharmD

Payer Drug and Molecular Testing Utilization Policies

Charles Bankhead, Medical Writer

Hardworking P&T Committees

David B. Nash, MD, MBA

Practice Management

"Hidden” Value: How Indirect Benefits of Health Information Exchange Further Promote Sustainability

Albert Tzeel, MD, MHSA, CPE, FAAPL, Victor Lawnicki, PhD, Kim R. Pemble, MS

Stakeholder Perspective

Significant Potential for Health Information Exchange in Enhancing Quality of Care and Reducing Hospital Admissions in the United States

by Jack E. Fincham, PhD, RPh

Cardiometabolic Health

Sustained Glycemic Control with Once-Weekly Exenatide Reduces Cardiometabolic Risk Factors

Cardiometabolic Health

Incretin Therapies Lower Cardiovascular Risk Score

Cardiometabolic Health

UKPDS Follow-Up: Early HbA1c Reductions Linked to a Decrease in MI, All-Cause Mortality

The Diabetes Epidemic Is Like a Tsunami Hitting in Waves

Medical Costs Increase as Chronic Kidney Disease Worsens

Cardiometabolic Health

Diabetes Rates Surging Among American Youth

Page 191 of 244
Results 1901 - 1910 of 2438